Evaluation of Evidence for Pathogenicity Demonstrates That BLK, KLF11, and PAX4 Should Not Be Included in Diagnostic Testing for MODY

Maturity Onset Diabetes of the Young (MODY) is an autosomal dominant form of monogenic diabetes, reported to be caused by variants in 16 genes. Concern has been raised about whether variants in BLK (MODY11), KLF11 (MODY7) and PAX4 (MODY9) cause MODY. We examined variant-level genetic evidence (co-segregation with diabetes and frequency in population) for published putative pathogenic variants in these genes and used burden testing to test gene-level evidence in a MODY cohort (n=1227) compared to population control (UK Biobank, n=185,898). For comparison we analysed well-established causes of MODY, HNF1A and HNF4A. The published variants in BLK, KLF11 and PAX4 showed poor co-segregation with diabetes (combined LOD scores [≤]1.2), compared to HNF1A and HNF4A (LOD scores >9), and are all too common to cause MODY (minor allele frequency >4.95x10-5). Ultra-rare missense and protein-truncating variants (PTVs) were not enriched in a MODY cohort compared to the UK Biobank (PTVs P>0.05, missense P>0.1 for all three genes) while HNF1A and HNF4A were enriched (P<10-6). Sensitivity analyses using different population cohorts supported our results. Variant and gene-level genetic evidence does not support BLK, KLF11 or PAX4 as causes of MODY. They should not be included in MODY diagnostic genetic testing.

[1]  Alexander E. Lopez,et al.  Advancing Human Genetics Research and Drug Discovery through Exome Sequencing of the UK Biobank , 2020, medRxiv.

[2]  Katherine R. Smith,et al.  PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels , 2019, Nature Genetics.

[3]  Zhuang Ming-Qiang,et al.  Maturity onset diabetes of the young (MODY) in Chinese children: genes and clinical phenotypes , 2019, Journal of pediatric endocrinology & metabolism : JPEM.

[4]  Tanya M. Teslovich,et al.  Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls , 2019, Nature.

[5]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[6]  P. Donnelly,et al.  The UK Biobank resource with deep phenotyping and genomic data , 2018, Nature.

[7]  Y. J. Kim,et al.  Nonsynonymous Variants in PAX4 and GLP1R Are Associated With Type 2 Diabetes in an East Asian Population , 2018, Diabetes.

[8]  K. Owen Monogenic diabetes in adults: what are the new developments? , 2018, Current opinion in genetics & development.

[9]  N. White,et al.  Monogenic Diabetes in Overweight and Obese Youth Diagnosed with Type 2 Diabetes: The TODAY Clinical Trial , 2017, Genetics in Medicine.

[10]  A. Hattersley,et al.  Precision diabetes: learning from monogenic diabetes , 2017, Diabetologia.

[11]  J. Michael Cherry,et al.  Evaluating the clinical validity of gene-disease associations: an evidence-based framework developed by the Clinical Genome Resource , 2017, bioRxiv.

[12]  N. Thomas,et al.  Comprehensive Maturity Onset Diabetes of the Young (MODY) Gene Screening in Pregnant Women with Diabetes in India , 2017, PloS one.

[13]  D. MacArthur,et al.  Using high-resolution variant frequencies to empower clinical genome interpretation , 2016, Genetics in Medicine.

[14]  Stephen C. J. Parker,et al.  The genetic architecture of type 2 diabetes , 2016, Nature.

[15]  B. Shields,et al.  Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes , 2016, Diabetes Care.

[16]  B. Özkan,et al.  Molecular diagnosis of maturity-onset diabetes of the young (MODY) in Turkish children by using targeted next-generation sequencing , 2015, Journal of pediatric endocrinology & metabolism : JPEM.

[17]  James Y. Zou Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[18]  Heidi L Rehm,et al.  ClinGen--the Clinical Genome Resource. , 2015, The New England journal of medicine.

[19]  N. Thomas,et al.  Maturity onset diabetes of the young in India – a distinctive mutation pattern identified through targeted next‐generation sequencing , 2015, Clinical endocrinology.

[20]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[21]  François Schiettecatte,et al.  OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders , 2014, Nucleic Acids Res..

[22]  D. G. MacArthur,et al.  Guidelines for investigating causality of sequence variants in human disease , 2014, Nature.

[23]  M. Weedon,et al.  Improved genetic testing for monogenic diabetes using targeted next-generation sequencing , 2013, Diabetologia.

[24]  A. Hattersley,et al.  Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth. , 2013, The Journal of clinical endocrinology and metabolism.

[25]  S. Ellard,et al.  Mutations in the Genes Encoding the Transcription Factors Hepatocyte Nuclear Factor 1 Alpha and 4 Alpha in Maturity‐Onset Diabetes of the Young and Hyperinsulinemic Hypoglycemia , 2013, Human mutation.

[26]  T. Hansen,et al.  Reassessment of the putative role of BLK-p.A71T loss-of-function mutation in MODY and type 2 diabetes , 2013, Diabetologia.

[27]  B. Shields,et al.  Maturity-onset diabetes of the young (MODY): how many cases are we missing? , 2010, Diabetologia.

[28]  S. Bonner-Weir,et al.  Mutations at the BLK locus linked to maturity onset diabetes of the young and β-cell dysfunction , 2009, Proceedings of the National Academy of Sciences.

[29]  Jon Wakefield,et al.  A Bayesian measure of the probability of false discovery in genetic epidemiology studies. , 2007, American journal of human genetics.

[30]  K. Nanjo,et al.  PAX4 mutations in Thais with maturity onset diabetes of the young. , 2007, The Journal of clinical endocrinology and metabolism.

[31]  T. Hansen,et al.  Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell function. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[32]  S. Weremowicz,et al.  Identification of a locus for maturity-onset diabetes of the young on chromosome 8p23. , 2004, Diabetes.

[33]  P. Stenson,et al.  Human Gene Mutation Database (HGMD®): 2003 update , 2003, Human mutation.

[34]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[35]  T. Sanke,et al.  A missense mutation of Pax4 gene (R121W) is associated with type 2 diabetes in Japanese. , 2001, Diabetes.

[36]  D. Valle,et al.  Online Mendelian Inheritance In Man (OMIM) , 2000, Human mutation.

[37]  G. Bell,et al.  Organization and Partial Sequence of the Hepatocyte Nuclear Factor-4α/MODY1 Gene and Identification of a Missense Mutation, R127W, in a Japanese Family With MODY , 1997, Diabetes.

[38]  G. Bell,et al.  Hepatic function in a family with a nonsense mutation (R154X) in the hepatocyte nuclear factor-4alpha/MODY1 gene. , 1997, The Journal of clinical investigation.

[39]  T. Hansen,et al.  Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3) , 1996, Nature.

[40]  Lawyer,et al.  The Japanese , 2017 .

[41]  古田 浩人 Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1) , 1999 .

[42]  M. Stoffel,et al.  Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1) , 1996, Nature.